| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 03/26/2009 | US20090081178 Phenolic Binding Peptides |
| 03/26/2009 | US20090078574 Charge tags and the separation of nucleic acid molecules |
| 03/26/2009 | US20090078384 Esterases from rumen |
| 03/26/2009 | CA2706889A1 Mutant pyrrolysyl-trna synthetase, and method for production of protein having non-natural amino acid integrated therein by using the same |
| 03/26/2009 | CA2698130A1 Modified xylan production |
| 03/25/2009 | EP2039779A1 Screening method |
| 03/25/2009 | EP2039774A1 Methods for the production of products in host cells |
| 03/25/2009 | EP2039764A1 Truncated secretory aspartyl proteinase 2 |
| 03/25/2009 | EP2039763A1 Production of peroxidase from plant cell and callus cultures |
| 03/25/2009 | EP2039762A2 Nitralases |
| 03/25/2009 | EP2038424A2 Stabilized proteins |
| 03/25/2009 | EP2038416A1 Nitrogen limitation adaptibility gene and protein and modulation thereof |
| 03/25/2009 | EP2038412A1 Polynucleotides encoding caryophyllene synthase and uses thereof |
| 03/25/2009 | EP2038411A1 Modified beta-lactamase and method for its preparation |
| 03/25/2009 | EP2038410A1 Bacterial alpha-amylase variants |
| 03/25/2009 | EP2038409A2 Novel human acidic mammalian chitinase and use thereof |
| 03/25/2009 | EP2038408A1 Preparation of dough and baked products |
| 03/25/2009 | EP2038407A1 Proteins with esterase activity |
| 03/25/2009 | EP2038406A2 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
| 03/25/2009 | EP2038405A2 Methods and systems for increasing production of equilibrium reactions |
| 03/25/2009 | EP2038403A1 Mutant microorganism having improved production ability of branched amino acid and method for preparing branched amino acid using the same |
| 03/25/2009 | EP1979481A4 Methods and compositions for ethanol producing cyanobacteria |
| 03/25/2009 | EP1917352A4 Methods and compositions for expressing a heterologous protease |
| 03/25/2009 | EP1631664B1 Feedback-resistant mevalonate kinases |
| 03/25/2009 | EP1543127B1 Nucleic acid sequences coding for proteolytic enzymes in the form of specific proteases, corresponding polypeptides and use of the same |
| 03/25/2009 | EP1500704B1 Expression system of actinomycete-origin cytochrome p-450 in escherichia coli |
| 03/25/2009 | EP1499748B1 Hepatitis c virus assay systems |
| 03/25/2009 | EP1476539B1 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins |
| 03/25/2009 | EP1352057B1 Lipolytic enzyme variant |
| 03/25/2009 | EP1306383B1 Method of purifying a calcium ion-binding protein |
| 03/25/2009 | EP1242587B1 A NOVEL ISOFORM OF HUMAN cAMP-DEPENDENT PROTEIN KINASE, C ALPHA-s, LOCALIZES TO SPERM MIDPIECE AND THE USE THEREOF |
| 03/25/2009 | EP1141291B1 Method for the cellular high-throughput-detection of nuclear receptor ligand interactions |
| 03/25/2009 | EP0960197B1 GENES FROM 20q13 AMPLICON AND THEIR USES |
| 03/25/2009 | CN101395276A Epsp synthase enzyme domains conferring glyphosate resistance |
| 03/25/2009 | CN101395271A Aspartate aminotransferase gene and method for production of l-phosphinothricin |
| 03/25/2009 | CN101395269A Proteases, nucleic acids encoding them and methods for making and using them |
| 03/25/2009 | CN101395268A Synergistic effect between a cyanogenic system and another oxidative inducer for the treatment of tumours |
| 03/25/2009 | CN101395264A Recombinant microorganism |
| 03/25/2009 | CN101395263A Methods of making modular fusion protein expression products |
| 03/25/2009 | CN101392266A High temperature and strong alkali resistant xylanase improved gene, genetic engineering bacterial strain thereof and preparation method thereof |
| 03/25/2009 | CN101392265A Novel xylanase gene and production method of recombinase thereof |
| 03/25/2009 | CN101392263A Acetyl esterase and coding gene thereof |
| 03/25/2009 | CN101392262A Polypeptide of fungal ubuquitin-conjugating enzyme, coding sequence thereof and preparation method and application |
| 03/25/2009 | CN101392243A Establishment of high yield alkali protein concentration and extraction process |
| 03/25/2009 | CN101392242A Alpha-glucosidase, gene thereof, preparation method, vector and host cell |
| 03/25/2009 | CN101392241A Beta-mannanase, gene, preparation method, vector and host cell |
| 03/25/2009 | CN101392240A Methods for concentrating and purifying nuclease P1 by nanofiltration and producing nucleotide |
| 03/25/2009 | CN101392233A Method for expression of granular methane monooxygenase and special engineering strain thereof |
| 03/25/2009 | CN101392230A Recombinant escherichia coli for expression of adenomethionine synthetase |
| 03/25/2009 | CN101392224A Aspergillus niger strain for high yield of chlorogenic acid hydrolase and use thereof |
| 03/25/2009 | CN101391105A Gene therapy for critical limb ischemia with wild type or mutant eNOS |
| 03/25/2009 | CN100471950C Polypeptides having alpha- h-alpha-amino acid amide racemase activity and nucleic acids encoding the same |
| 03/25/2009 | CN100471949C Variant serine acetyltransferase and process for producing L-cysteine |
| 03/25/2009 | CN100471850C Epigallocatechin dimers or trimers having lipase inhibitory activity and/or antioxidative activity |
| 03/24/2009 | US7507752 A C9-deoxomeridamycin, used as a neuroregenerative agent |
| 03/24/2009 | US7507711 A PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof |
| 03/24/2009 | US7507570 Recombinant chondroitinase ABC I and uses thereof |
| 03/24/2009 | US7507569 hydrolase enzymes comprising amino acid sequence having replacements, deletions or insertion , used in cleaning compounds or detergents having improved wash performance on egg stains |
| 03/24/2009 | US7507568 Human Protein Tyrosine Phosphatase (HPTP); crystal structures of catalytic domain of HPTPbeta; useful in computer aided drug design for identifying compounds that bind or activate HPTPbeta and thereby modulate angiogenesis mediated disorders |
| 03/24/2009 | US7507567 RNA polymerase mutants with increased thermostability |
| 03/24/2009 | US7507566 Flavone synthases, methods of using flavone synthases, and plants expressing flavone synthases |
| 03/24/2009 | US7507565 Bioluminescence resonance energy transfer (BRET) systems and methods of use thereof |
| 03/24/2009 | US7507559 reacting acyclic carboxy amines with 5,10-methylene tetrahydrofolic acid in the presence of formaldehyde and a protein derived from a microorganism, to form oxy carboxy amines and its optically-active isomers |
| 03/24/2009 | US7507558 Processes for producing inulin |
| 03/24/2009 | US7507557 Nucleotide sequences coding proline utilization protein (PUT2) for use as tool in prevention and treatment of insulin metabolic disorders |
| 03/24/2009 | US7507556 Expresion vector comprising nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatment of cell adhesion, proliferation, inflammatory disorders; wound healing agents |
| 03/24/2009 | US7507555 polypeptides linked to chromogens capable of fluorescence resonance energy transfer, used for the quantitative analysis of molecules that relay signals received at receptors on a cell surface to target molecules in the cytosol and/or nucleus |
| 03/24/2009 | US7507552 Crystallization of histone deacetylase 2 |
| 03/24/2009 | US7507540 determining the presence of catalytic antibodies capable of degrading antihemophilic factors in mammals; analyzing the cleavage sites in the antihemophilic factors; biocatalysts; drugs |
| 03/24/2009 | US7507414 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 03/24/2009 | US7507404 PRO polypeptides; monoclonal/humanized antibodies; fusion proteins |
| 03/24/2009 | US7507403 drugs comprising an isolated protein, mixed with pharmaceutically acceptable carriers, excipients or diluents, used as an immunogenic composition for stimulating or enhancing the production of antibodies directed against the protein |
| 03/24/2009 | CA2320717C Method for the treatment of diseases or disorders of the inner ear |
| 03/24/2009 | CA2318479C G protein-related kinase mutants in essential hypertension |
| 03/24/2009 | CA2199853C Microorganisms and methods for overproduction of dahp by cloned pps gene |
| 03/24/2009 | CA2176373C Farnesyl derivatives and pharmaceutical compositions containing them |
| 03/19/2009 | WO2009036404A2 Ketoreductase polypeptides for the reduction of acetophenones |
| 03/19/2009 | WO2009035537A1 Beta-glucosidase enhanced filamentous fungal whole cellulase compositions and methods of use |
| 03/19/2009 | WO2009034414A1 Method for fermenting cellulosics |
| 03/19/2009 | WO2009034395A1 Method and means relating to multiple herbicide resistance in transgenic plants |
| 03/19/2009 | WO2009034328A2 Two step cluster deletion and humanisation |
| 03/19/2009 | WO2009034159A1 Short polypeptide mediated conformational changes promoting enhancement of enzymatic activity |
| 03/19/2009 | WO2009034158A2 Transgenic mice |
| 03/19/2009 | WO2009033957A1 Process for preparing enantiomerically enriched amines |
| 03/19/2009 | WO2009033670A2 Method and kits for dissociating fcgamma-receptor-igg complexes and for igg purification and detection |
| 03/19/2009 | WO2009033536A1 Recombinant preparation of selected bromelain fractions |
| 03/19/2009 | WO2009033293A1 Protein tyrosine phosphatase 1b and cancer |
| 03/19/2009 | WO2009033282A1 Mitogen-activated protein kinase kinase kinase 14 (map3k14) polymorphisms as indicators of subject outcome in critically ill subjects |
| 03/19/2009 | WO2009013622A3 Meganuclease variants cleaving a dna target sequence from the human hemoglobin beta gene and uses thereof |
| 03/19/2009 | WO2009012982A3 Process |
| 03/19/2009 | WO2008156551A3 Tat signal peptides for producing proteins in prokaryotes |
| 03/19/2009 | WO2008155665A3 Method for enhancing cellobiose utilization |
| 03/19/2009 | WO2008130814A3 Use of an mmp28 inhibitor for increasing myelination |
| 03/19/2009 | WO2008127702A3 Modified factor vii polypetides and uses thereof |
| 03/19/2009 | WO2008091288A3 Microbial synthesis of d-1,2,4-butanetriol |
| 03/19/2009 | WO2008055625A3 Polypeptide having phytase activity and increased temperature resistance of the enzyme activity, and nucleotide sequence coding said polypeptide |
| 03/19/2009 | WO2007029200A9 Ssb - polymerase fusion proteins |
| 03/19/2009 | WO2005077125A3 Methods and compositions for detecting nucleic acids |
| 03/19/2009 | US20090077692 Production of gamma linolenic acid by a delta6-desaturase |
| 03/19/2009 | US20090076248 Plus end-directed microtubule motor required for chromosome congression |